Ophthalmic Business News

FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress here, Nancy Lurker, president and CEO of EyePoint Pharmaceuticals, discusses the latest update on EYP-1901.

Few have as much need for asset protection as physicians. As high-income earners, physicians often have substantial financial assets and real property that needs to be removed from risks of loss due to liability, malpractice claims, worker complaints, cyberattacks, HIPAA violations and more.

Hosts Jim Mazzo and John A. Hovanesian, MD, FACS, discuss the latest ophthalmic industry news and interview Eve Higginbotham, MD.

Johnson & Johnson Vision announced the appointment of Peter Menziuso as company group chairman in a press release.

In this Healio Video Perspective, Bobak Azamian, MD, PhD, CEO and co-founder of Tarsus Pharmaceuticals, discusses topline data from the Saturn-2 phase 3 study of TP-03 for the treatment of Demodex blepharitis.

One of the most important components of a sound financial strategy is to mitigate risk.

WASHINGTON — In this Healio Video Perspective from Eyecelerator@ASCRS, Ben Bergo, CEO of Visus Therapeutics, discusses the results of the VIVID phase 2 study of presbyopia drop formulations in patients with emmetropic presbyopia.

CHICAGO — The ACP recently released a position paper that lays out recommendations for improving communication between primary care and specialty physicians, which in turn will improve patient care.

In this episode, Dhruvin Patel, MCOptom, discusses the short- and long-term effects of blue light on our eyes, how the pandemic has exacerbated these effects and how his company, Ocushield, is looking to help protect eyes from blue light.

With a total of 200,672 procedures, laser vision correction procedure volume increased by 5.3% in the first quarter of 2022 over the fourth quarter of 2021, according to a report from the Refractive Surgery Council.